Spinal fusion using an HMG-CoA reductase inhibitor

Details Spinal fusion using an HMG-CoA reductase inhibitor Spinal fusion using an HMG-CoA reductase inhibitor

2006-05-09

2006-05-09

Azpuru, Carlos A. (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Implant or insert

C424S423000, C424S424000, C424S425000, C523S113000, C523S116000

Reexamination Certificate

active

07041309

ABSTRACT:
An improved technique for spinal fusion including administration of an HMG-CoA reductase inhibitor to the fusion site. The HMG-CoA reductase inhibitor is preferably delivered to the site by a carrier. More preferably, the HMG-CoA reductase inhibitor is delivered to the site by a noncompressible delivery vehicle. The invention is suitable for promoting non-anatomic or heterotopic bone growth between any bony surfaces where bone growth is desired but does not naturally occur.

REFERENCES:
patent: 4870063 (1989-09-01), Binderup et al.
patent: 5258376 (1993-11-01), Bernstein
patent: 5280040 (1994-01-01), Labroo et al.
patent: 5336687 (1994-08-01), Sabatucci
patent: 5403829 (1995-04-01), Lehtinen et al.
patent: 5462932 (1995-10-01), Brenner et al.
patent: 5545661 (1996-08-01), Cullinan
patent: 5604257 (1997-02-01), Tabe et al.
patent: 5935607 (1999-08-01), Silver
patent: 6022887 (2000-02-01), Gasper et al.
patent: 6040334 (2000-03-01), Myers et al.
patent: 6080779 (2000-06-01), Gasper et al.
patent: 6083690 (2000-07-01), Harris et al.
patent: 6153212 (2000-11-01), Mao et al.
patent: 6207153 (2001-03-01), Dan et al.
patent: 6322797 (2001-11-01), Mao et al.
patent: 6369109 (2002-04-01), Debatin et al.
patent: 6376476 (2002-04-01), Gasper et al.
patent: 6376644 (2002-04-01), Mao et al.
patent: 6403637 (2002-06-01), Partridge
patent: 6462019 (2002-10-01), Mundy et al.
patent: WO03105731 (2003-12-01), None
“Instructions for Use: Cook-Swartz Doppler Flow Probe and Monitoring System”, 1998 Cook Vascular Incorporated FM-15588 Aug. 1999.
Pilitsis, M.D., Julie G. et al., “Bone Healing And Spinal Fusion,”Neurosur. Focus 13(6); Article 1, vol. 13, (2002), pp. 1-6.
Csizy, M. et al., “Displaced Intra-Articular Calcaneal Fractures”Journal of Orthopaedic Trauma, vol. 17, No. 2, pp. 106-112.
Edwards, Richard C. et al., “Fixation of Bimaxillary Osteotomies With Resorbable Plates And Screws: Experience in 20 Consecutive Cases,”J. Oral Maxillofac. Surg. (2001) 59: pp. 271-276.
Fadel, G.E. et al., “Hallux Metatarsophalangeal Joint Arthrodesis: Various Techniques,”The Foot, (2002, 12, pp. 88-96.
Fearon, M.D., J., “Rigid Fixation Of The Calvaria In Craniosysnostosis Without Using “Rigid” Fixation,”Plastic And Reconstructive Surgery, (2003) pp. 27-38.
Hendricks, M.D., R.L., “Bone Morphogenic Protein,”Annual Workers' Compensation Seminar, (1998) pp. 1-3.
Jones, S. et al., “Arthrodesis For Failed Ankle Arthoplasty: A Technique Using The Fibula As An Autogeneous Bone Graft,”The Foot, (1999), 9, pp. 142-144.
Mundy, G. et al., “Stimulation of Bone Formation in Vitro And In Rodents by Statins,”Science, (1999) vol. 286, pp. 1946-1949.
Schwetlick, G. et al., “Results of Arthrodesis And Operative Stabilization of Osteotomies With A Compression Staple System,”The Foot, (2003) pp. 100-107.
Wozney, J. M., et al., “Engineering What Comes Naturally—Tissue engineers have developed a synthetic matrix that interacts with host cells to deliver bone-inductive proteins for bone regeneration.”Nature Biotechnology. May 2003. vol. 21: 506-508.

Affiliated with

Also associated with

Rating

Spinal fusion using an HMG-CoA reductase inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Spinal fusion using an HMG-CoA reductase inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spinal fusion using an HMG-CoA reductase inhibitor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3648175